Nantahala Capital Management, LLC Akebia Therapeutics, Inc. Transaction History

Nantahala Capital Management, LLC

$1.68 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.26 - $3.34 $134,763 - $199,164	-59,630 Reduced 1.2%	4,918,565 $11.1 Million
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.88 $450,889 - $744,447	-191,868 Reduced 3.71%	4,978,195 $14.3 Million
Q2 2021 Aug 16, 2021	BUY	$2.83 - $4.2 $54,460 - $80,824	19,244 Added 0.37%	5,170,063 $19.6 Million
Q1 2021 May 14, 2021	SELL	$2.92 - $5.06 $5.52 Million - $9.56 Million	-1,889,668 Reduced 26.84%	5,150,819 $17.4 Million
Q4 2020 Feb 16, 2021	BUY	$2.22 - $3.78 $2.87 Million - $4.89 Million	1,293,864 Added 22.52%	7,040,487 $19.7 Million
Q3 2020 Nov 16, 2020	SELL	$2.39 - $13.08 $847,226 - $4.64 Million	-354,488 Reduced 5.81%	5,746,623 $14.4 Million
Q2 2020 Aug 14, 2020	SELL	$6.67 - $13.58 $3.06 Million - $6.22 Million	-458,367 Reduced 6.99%	6,101,111 $82.9 Million
Q1 2020 May 14, 2020	SELL	$4.1 - $10.24 $728,332 - $1.82 Million	-177,642 Reduced 2.64%	6,559,478 $49.7 Million
Q4 2019 Feb 14, 2020	BUY	$3.16 - $6.73 $2.99 Million - $6.38 Million	947,559 Added 16.37%	6,737,120 $42.6 Million
Q2 2019 Aug 14, 2019	BUY	$4.1 - $8.05 $3.48 Million - $6.83 Million	848,500 Added 17.17%	5,789,561 $28 Million
Q1 2019 May 15, 2019	SELL	$5.41 - $8.73 $665,581 - $1.07 Million	-123,028 Reduced 2.43%	4,941,061 $40.5 Million
Q4 2018 Feb 14, 2019	BUY	$5.39 - $9.15 $1.83 Million - $3.11 Million	339,878 Added 7.19%	5,064,089 $28 Million
Q3 2018 Nov 14, 2018	BUY	$7.44 - $10.65 $1.5 Million - $2.14 Million	201,100 Added 4.45%	4,724,211 $41.7 Million
Q2 2018 Aug 14, 2018	BUY	$9.15 - $11.34 $10.4 Million - $12.9 Million	1,136,968 Added 33.58%	4,523,111 $45.1 Million
Q1 2018 May 15, 2018	BUY	$9.53 - $15.68 $13.8 Million - $22.8 Million	1,452,276 Added 75.1%	3,386,143 $32.3 Million
Q4 2017 Feb 14, 2018	BUY	$14.24 - $19.59 $8.06 Million - $11.1 Million	565,920 Added 41.37%	1,933,867 $28.8 Million
Q3 2017 Nov 14, 2017	BUY	$13.06 - $19.67 $17.9 Million - $26.9 Million	1,367,947	1,367,947 $26.9 Million

Others Institutions Holding AKBA

# of Institutions

121

Shares Held

54.8M

Call Options Held

291K

Put Options Held

179K

Black Rock Inc. New York, NY

11.6M
Shares

$20.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$18 Million
0.0% of portfolio
Satter Management Co., L.P.

5.75M
Shares

$10.3 Million
13.23% of portfolio
Geode Capital Management, LLC Boston, MA

4.75M
Shares

$8.51 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

3.72M
Shares

$6.65 Million
0.01% of portfolio

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $329M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Account